MR Finds MS Predictor

by User Not Found | Jun 01, 2013
Dr. Robert Zivadinov, MD, PhD, FAAN, from the Buffalo Neuroimaging Analysis Center at the University at Buffalo, and his colleagues, conducted a two year study on the link between the development of thalamic atrophy and the conversion to clinically definite multiple sclerosis (MS).

Dr. Robert Zivadinov, MD, PhD, FAAN, from the Buffalo Neuroimaging Analysis Center at the University at Buffalo, and his colleagues, conducted a two year study on the link between the development of thalamic atrophy and the conversion to clinically definite multiple sclerosis (MS).

Dr. Zivadinov said, “For some time we’ve been trying to understand MRI biomarkers that predict MS development from the first onset of the disease. In the last couple of years, research has become much more focused on the thalamus.”

Using enhanced MRI the group studied 216 patients with clinically isolated syndrome (CIS), a short-term neurologic event experienced by 85% of MS patients. The patients were then studied again at six month, one year and two years. 42.6% of the patients had developed clinically definite MS at the two year follow-up MR.

“Thalamic atrophy may become a hallmark of how we look at the disease and how we develop drugs to treat it.”, said Zivadinov.

Joe Calandra CMO, Midwest Imaging Professionals
Joe Calandra - CMO, Midwest Imaging Professionals
View More Testimonials
Rob
Complimentary Practice
Analysis
Contact Us
newsletter